The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new research intended to improve the care of patients with cutaneous ...

Teddi Mellencamp reveals the physical and emotional challenges of brain surgery and stage 4 cancer Read ahead to know about ...

Company management estimates that approximately 7,000 patients annually in the United States are affected by HER2-negative metastatic breast cancer with liver metastases and are candidates for ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.

Delcath Systems, Inc. announced that it has received clearance from the FDA to initiate patient enrollment of a phase 2 clinical ...

Symptoms, and Treatment Liver cancer is one of the most challenging forms of cancer, often developing quietly before showing any clear signs. It begins when abnormal cells form in the liver, a vital ...

HEPZATO KIT is approved as a liver-directed treatment for adult patients with metastatic uveal melanoma (mUM ... subcutaneous tissues, or lung that is amenable to resection or radiation.

Medically reviewed by Matthew Wosnitzer, MD Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of prostate cancer. Metastatic means the cancer has spread from the prostate to ...